Ihor Arkhypov

1.0k total citations · 1 hit paper
11 papers, 677 citations indexed

About

Ihor Arkhypov is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ihor Arkhypov has authored 11 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Ihor Arkhypov's work include Immune cells in cancer (7 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Ihor Arkhypov is often cited by papers focused on Immune cells in cancer (7 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Ihor Arkhypov collaborates with scholars based in Germany, United States and Israel. Ihor Arkhypov's co-authors include Jochen Utikal, Samantha Lasser, Viktor Umansky, Feyza Gül Özbay Kurt, Peter Altevogt, Vera Petrova, Christopher Groth, Rebekka Weber, Viktor Umansky and Daniel Novak and has published in prestigious journals such as Journal of Clinical Investigation, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Ihor Arkhypov

11 papers receiving 676 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myeloid-derived suppressor cells in cancer and cancer therapy

2024 215 citations Samantha Lasser, Feyza Gül Özbay Kurt et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ihor Arkhypov Germany	10	402	286	228	101	71	11	677
Samantha Lasser Germany	9	427 1.1×	284 1.0×	236 1.0×	105 1.0×	75 1.1×	11	697
Feyza Gül Özbay Kurt Germany	10	287 0.7×	192 0.7×	159 0.7×	59 0.6×	69 1.0×	14	543
Hannah H. Yan United States	7	377 0.9×	350 1.2×	236 1.0×	86 0.9×	42 0.6×	13	667
C Blattner Germany	9	671 1.7×	464 1.6×	210 0.9×	79 0.8×	57 0.8×	9	892
Angela M. Gocher United States	5	320 0.8×	326 1.1×	264 1.2×	94 0.9×	50 0.7×	7	662
Janina Dörr Germany	2	263 0.7×	253 0.9×	177 0.8×	59 0.6×	53 0.7×	2	530
Sugandha Saxena United States	14	407 1.0×	438 1.5×	228 1.0×	103 1.0×	64 0.9×	28	832
Won Jong Jin United States	14	215 0.5×	286 1.0×	228 1.0×	66 0.7×	32 0.5×	27	583
Jian Ye United States	12	800 2.0×	517 1.8×	252 1.1×	133 1.3×	51 0.7×	17	1.1k
Konstantinos Lontos United States	11	260 0.6×	250 0.9×	164 0.7×	75 0.7×	57 0.8×	32	570

Countries citing papers authored by Ihor Arkhypov

Since Specialization

Citations

This map shows the geographic impact of Ihor Arkhypov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ihor Arkhypov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ihor Arkhypov more than expected).

Fields of papers citing papers by Ihor Arkhypov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ihor Arkhypov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ihor Arkhypov. The network helps show where Ihor Arkhypov may publish in the future.

Co-authorship network of co-authors of Ihor Arkhypov

This figure shows the co-authorship network connecting the top 25 collaborators of Ihor Arkhypov. A scholar is included among the top collaborators of Ihor Arkhypov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ihor Arkhypov. Ihor Arkhypov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Lasser, Samantha, Feyza Gül Özbay Kurt, Ihor Arkhypov, Jochen Utikal, & Viktor Umansky. (2024). Myeloid-derived suppressor cells in cancer and cancer therapy. Nature Reviews Clinical Oncology. 21(2). 147–164. 215 indexed citations breakdown →

2.

Petrova, Vera, Christopher Groth, Ihor Arkhypov, et al.. (2023). Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients. Frontiers in Immunology. 14. 12 indexed citations

3.

Kurt, Feyza Gül Özbay, et al.. (2023). Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs. OncoImmunology. 12(1). 2247303–2247303. 8 indexed citations

4.

Kurt, Feyza Gül Özbay, Samantha Lasser, Ihor Arkhypov, Jochen Utikal, & Viktor Umansky. (2023). Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target. Journal of Clinical Investigation. 133(13). 63 indexed citations

5.

Arkhypov, Ihor, Feyza Gül Özbay Kurt, Daniel Novak, et al.. (2022). HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling. Journal for ImmunoTherapy of Cancer. 10(9). e005551–e005551. 32 indexed citations

6.

Kurt, Feyza Gül Özbay, Samantha Lasser, Ihor Arkhypov, et al.. (2022). Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2. Frontiers in Immunology. 13. 1012526–1012526. 21 indexed citations

7.

Groth, Christopher, Ludovica Arpinati, Merav E. Shaul, et al.. (2021). Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression. Cancers. 13(4). 726–726. 24 indexed citations

8.

Weber, Rebekka, Christopher Groth, Samantha Lasser, et al.. (2020). IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cellular Immunology. 359. 104254–104254. 219 indexed citations

9.

Hüser, Laura, Aniello Federico, Daniel Novak, et al.. (2020). HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma. Cancers. 12(12). 3761–3761. 9 indexed citations

10.

Petrova, Vera, Ihor Arkhypov, Rebekka Weber, et al.. (2020). Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma. International Journal of Molecular Sciences. 21(7). 2367–2367. 38 indexed citations

11.

Arkhypov, Ihor, Samantha Lasser, Vera Petrova, et al.. (2020). Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles. International Journal of Molecular Sciences. 21(17). 6319–6319. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact